COX-2 and iNOS expressions were upregulated under insulin resistance, obesity, hyperglycemia, and oxidative stress; therefore, the downregulations of COX-2 and iNOS through the oral administration of Kangen-karyu demonstrated the inhibition of pathogenic factors in type 2 diabetes. This evidence concerns the gene PTGS2 and Obesity.